Eligible participants accepted into the programme will be randomised based on an allocation sequence generated by an independent person not involved in the study through a true randomisation process (http://www.random.org).org
*Represents risk of bias based on: sequence generation of allocation; allocation concealment and blinding; + represents low risk of bias, − represents high risk of bias, and ± represents unclear risk.
Randomised clinical trials were graded based on sequence generation, allocation concealment, blinding, incomplete outcome data, selective outcome reporting, and other sources of bias.
25 The trials were graded (unclear, high, or low risk of bias) based on sequence generation, allocation concealment, blinding of outcome assessor, incomplete outcome data, and selective outcome reporting.
Assessment of risk of bias in the included studies was based on sequence generation, allocation concealment, blinding (of participants, personnel and outcome assessors), incomplete outcome data, selective outcome reporting and other sources of bias, such as baseline imbalance and early stopping bias.
21 The trials were graded (unclear, high or low risk of bias) based on: (1) sequence generation, (2) allocation concealment, (3) blinding of outcome assessor, (4) incomplete outcome data and (5) selective outcome reporting.
The precise formula is incredibly arcane, but the first five words capture the essence: "Allocation based on previous allocation".
The risk of bias tool is based on six domains: sequence generation, allocation concealment, blinding, incomplete outcome data, selective outcome reporting, and "other sources of bias".
Sequences were grouped into operational taxonomic units (OTUs) based on 97% sequence identity, and chimeric sequences were removed, using UPARSE60.
These natural milk protein genetic sequences are not actually from the animals, but based on the sequence found in animals.
